bioRxivMicrobiology
Replication of SARS-CoV-2 in human respiratory epithelium
A. Milewska, A. Kula-Pacurar, J. Wadas, A. Suder, A. Szczepanski, A. Dabrowska, K. Owczarek, M. Ochman, T. Stacel, Z. Rajfur, P. P. Labaj, W. Branicki, K. Pyrc
Abstract
SARS-CoV-2 emerged by the end of 2019 to rapidly spread in 2020. At present, it is of utmost importance to understand the virus biology and to rapidly assess the potential of existing drugs and develop new active compounds. While some animal models for such studies are under development, most of the research is carried out in the Vero E6 cells. Here, we propose fully differentiated human airway epithelium cultures as a model for studies on the SARS-CoV-2. Further, we also provide basic characteristics of the system.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery
- SARS-CoV-2 Viral Replication in a High Throughput Human Primary Epithelial Airway Organ Model
C. R. Fisher, F. M. Medie, … A. L. Gard·bioRxiv·Jun 15, 2021
- Susceptibility of well-differentiated airway epithelial cell cultures from domestic and wildlife animals to SARS-CoV-2
M. Gultom, M. Licheri, … R. Dijkman·bioRxiv·Nov 10, 2020
- Long Period Modeling SARS-CoV-2 Infection of in Vitro Cultured Polarized Human Airway Epithelium
- Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
H. Zarkoob, A. Allue-Guardia, … E. M. Lee·bioRxiv·May 11, 2021
- Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia
A. Pizzorno, B. Padey, … M. Rosa-Calatrava·bioRxiv·Mar 31, 2020